HMOX1 and non-small cell lung carcinoma: Overexpression of HO-1 or treatment of non-small-cell lung cancer cells with CO-releasing molecule-2 can downregulate the expression of miR-378, inhibit the expression and synthesis of angiogenesis-related factors, and then play an antitumor effect [17].